From: Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin
Cell Line
VMM18
2.0
DM6
2.3
VMM39
2.1
VMM5A
VMM12
2.4
DM331
1.7
DM122